Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2017, Article ID 1937107, 4 pages
https://doi.org/10.1155/2017/1937107
Case Report

Primary Pulmonary Lymphoma Presenting with Superior Vena Cava Syndrome in a Young Female

Interfaith Medical Centre, Brooklyn, NY, USA

Correspondence should be addressed to Divya Salhan; moc.liamg@ayvidnahlas

Received 7 April 2017; Accepted 11 July 2017; Published 8 August 2017

Academic Editor: Daniel T. Merrick

Copyright © 2017 Divya Salhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Shenoy, N. Malik, A. Nooka et al., “Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States,” Cancer, vol. 117, no. 11, pp. 2530–2540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. A. Armstrong, C. A. Perez, J. R. Simpson, and M. A. Hederman, “Role of irradiation in the management of superior vena cava syndrome,” International Journal of Radiation Oncology, Biology, Physics, vol. 13, no. 4, pp. 531–539, 1987. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Perez-Soler, P. McLaughlin, W. S. Velasquez et al., “Clinical features and results of management of superior vena cava syndrome secondary to lymphoma,” Journal of Clinical Oncology, vol. 2, no. 4, pp. 260–266, 1984. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Warburg, “On the facultative anaerobiosis of cancer cells and its use in chemotherapy,” Munchener Medizinische Wochenschrift, vol. 103, pp. 2504–2506, 1961. View at Google Scholar
  5. J. Svahn, M. C. Schiaffino, U. Caruso, M. Calvillo, G. Minniti, and C. Dufour, “Severe Lactic Acidosis Due to Thiamine Deficiency in a Patient with B-Cell Leukemia/Lymphoma on Total Parenteral Nutrition during High-Dose Methotrexate Therapy,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 12, pp. 965–968, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Block, “Lactic acidosis in malignancy and observations on its possible pathogenesis,” Annals of the New York Academy of Sciences, vol. 230, no. 1, pp. 94–102, 1974. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Lewis, C. I. Caskey, and E. K. Fishman, “Lymphoma of the lung: CT findings in 31 patients,” American Journal of Roentgenology, vol. 156, no. 4, pp. 711–714, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Hong, S. Park, J. Park et al., “CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy,” Annals of Hematology, vol. 91, no. 12, pp. 1897–1906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. M. Habermann, E. A. Weller, V. A. Morrison et al., “Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma,” Journal of Clinical Oncology, vol. 24, no. 19, pp. 3121–3127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Coiffier, E. Lepage, J. Brière et al., “Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma,” The New England Journal of Medicine, vol. 346, no. 4, pp. 235–242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Yoshino, T. Hirata, C. Takeuchi, J. Usuda, and M. Hosone, “A case of primary pulmonary diffuse large B-cell lymphoma diagnosed by transbronchial biopsy,” Annals of Thoracic and Cardiovascular Surgery, vol. 21, no. 4, pp. 396–398, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Tamaru, A. Mikata, M. Itami, and T. Takagi, “Study of vimentin expression in non-Hodgkin's lymphoma using paraffin sections,” Acta Pathologica Japonica, vol. 40, no. 7, pp. 517–521, 1990. View at Google Scholar · View at Scopus
  13. The International Non-Hodgkin's Lymphoma Prognostic Factors Project, “A predictive model for aggressive non-Hodgkin's lymphoma,” New England Journal of Medicine, vol. 329, no. 14, pp. 987–994, 1993. View at Publisher · View at Google Scholar